In 2017 there were three times as many venture capital funds (11) compared to the previous year (4). At the end of the year the indicator on the fund's transactions was recorded as similar as in 2016 — 391.
As of the end of 2017 new venture funds have intensified their activities in Russia: their number has increased almost threefold, from 4 to 11. On the other hand, foreign funds investing in Russian start-ups have significantly reduced in number. This is what Firrma magazine states in their rating, compiled with the support of RVC and Ernst & Young.
Over the next 12 years the world will see an intensive development of near-Earth and near-moon space. The only question is whether Russia will be involved. There are too few chances to become a great space power.
In December, Firrma traditionally presents its rating of venture capital funds’ activities in Russia. Being RVC's strategic partner, the rating is also supported by EY. Below you will find the main rating of funds as well as three additional ones: seed funds, novice funds and foreign funds that invest in Russian start-ups. Please note the main trends of 2017.
Roman Abramovich's Norma Investments and Pharmstandard International, a subsidiary of Pharmstandard, invested $ 6 million in the biotechnological start-up OncoTartis Inc, which is an American subsidiary of the Skolkovo resident Onkotartis, Vedomosti reports.
A "Silicon Valley" is expected to be developed in the Far East. Far East's high-tech enterprises will be able to apply for financial support from the regional fund of development and implementation of high technology.
The Russian Venture Capital Association (RVCA), in cooperation with the Venture Capital Innovation Fund (VCIF) presented the annual report "Overview of Private Equity and Venture Investment Market" covering 9 months of 2017. According to the report, the aggregate capitalization of private equity and venture investment funds showed an upward trend at the end of the third quarter in 2017 for the first time since 2013, exceeding the $ 21 billion mark.
At the IV Annual Forum "Ecosystem of Innovations" held on November 30 and December 1 in Sochi, the experts have summed up on performance of the Russian venture market. The forum was organized by the Russian Venture Company (RVC).
The Venture Fund InVenture Partners sold its stake in the Busfor start-up to Elbrus Capital and Baring Vostok funds, said Anton Inshutin, Managing Partner of InVenture Partners, Ilya Yekushevsky, Busfor co-founder and representative of Baring Vostok. The partners do not disclose the sums and details of transactions.
The riskiness of venture investments is most clearly demonstrated by "survival" of start-ups. In 2015, the University of Tennessee conducted a study that showed that 44% of start-ups cease to exist within the first three years of their operation.
Vademecum became aware of details of the state program for creating artificial intelligence for the healthcare industry. The Agency for Strategic Initiatives and SkolTech are completing their work on CoBrain-Analytics algorithm, which, according to the authors’ concept, will be able to offer possible diagnoses and prescribe a personal treatment for patients with brain diseases.